Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
This study is ongoing, but not recruiting participants.
Sponsor:
Prosensa Therapeutics
Information provided by (Responsible Party):
Prosensa Therapeutics
ClinicalTrials.gov Identifier:
NCT01037309
First received: December 21, 2009
Last updated: October 10, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | March 2013 (Final data collection date for primary outcome measure) |